Table 3.

The effects of puerarin on hippocampal monoamine neurotransmitter levels in CUS rats.

Groups	5-HT	5-HIAA	NE	AD	HVA	DA	DOPAC
CUS (−)	205.5 ± 33.45	145.7 ± 25.66	140.7 ± 24.38	172.7 ± 24.49	47.17 ± 6.358	36.50 ± 5.602	49.83 ± 5.449
CUS (+)	99.17 ± 12.04##	58.83 ± 8.328##	123.7 ± 16.95	190.0 ± 24.24	44.33 ± 9.054	37.00 ± 6.282	45.50 ± 8.269
Ser 15 mg/kg, i.g	175.0 ± 19.23**	141.8 ± 17.66**	150.3 ± 12.39	193.5 ± 18.25	51.33 ± 6.136	30.50 ± 4.890	39.50 ± 4.904
puerarin 30 mg/kg, i.g	104.2 ± 6.194	92.33 ± 13.44	150.8 ± 20.49	176.5 ± 27.14	52.17 ± 8.856	33.67 ± 6.998	48.17 ± 7.748
puerarin 60 mg/kg, i.g	168.2 ± 12.62*	128.0 ± 24.85*	121.3 ± 15.81	205.8 ± 33.74	48.33 ± 8.617	39.33 ± 4.951	45.17 ± 4.020
puerarin 120 mg/kg, i.g	201.3 ± 30.03**	151.0 ± 28.28**	126.7 ± 21.50	190.5 ± 52.26	44.00 ± 4.389	38.17 ± 4.881	44.00 ± 5.342

^## p < 0.01 vs. vehicle-treated CUS (−) group; ^* p < 0.05, ^** p < 0.01 vs. vehicle-treated CUS (+) group (n = 6).